EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Pathogenic roles of antiganglioside antibodies in immune‐mediated neuropathies

Kenichi Kaida

Clinical and Experimental Neuroimmunology · 2013

DOI: 10.1111/cen3.12007 ↗
AbstractBibliografische Angaben

Abstract

Abstract Recent studies have shown that antiganglioside antibody‐mediated complement activation plays a key role in development of G uillain– B arré syndrome and related disorders. Additionally, complement‐independent nerve dysfunction is suggested by in vitro studies, showing that antiganglioside antibodies directly inhibit voltage‐gated C a channel currents and change the integrity of lipid rafts. These pathogenic actions of antiganglioside antibodies might be governed by the avidity of the antibodies, which is influenced by specific localization of target gangliosides in the peripheral nervous system or glycolipid environment around the target antigens. The recent discovery of antibodies to ganglioside complexes has expedited the understanding of the mechanisms underlying antiganglioside antibody‐mediated nerve dysfunction in G uillain– B arré syndrome and related disorders. In chronic immune‐mediated neuropathy, some antiganglioside antibodies have also been identified as diagnostic markers, although their pathophysiological roles remain to be determined.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →